Amedisys, Inc. AMED
Set alert
100.99 0.00 0.00%
At close · Aug 14
100.93 Day range 101.02
82.15 52-week range 101.02
- YTD
- +11.23%
- 1 year
- +3.24%
- Open
- 101.00
- Prev close
- 100.99
- Mkt cap
- 3.32B
- Vol
- 1.04M
- Avg vol
- 780.22K
- EPS
- 2.57
- P/E
- 19.86
- Div yield
- 0.00%
More statistics
- Low
- 100.93
- High
- 101.02
- Forward P/E
- 19.76
- Beta
- 0.90
- Short ratio
- 6.84
- Inst. own
- 96.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 29, 2025
- 50-d avg
- 98.01
- 200-d avg
- 93.25
- 1y target
- 0.00
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Ratings (0m) 6 1 buy · 4 hold · 1 sell
- Strong buy1
- Buy0
- Hold4
- Sell1
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 12
- 2 months ago 12
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.20 | 1.07 – 1.41 | 1.00 | +20.3% | 635.81M | +8.2% | 6 |
| Next quarter | 1.27 | 1.12 – 1.46 | 0.96 | +32.1% | 650.20M | +8.7% | 5 |
| Current year | 4.99 | 4.68 – 5.35 | 4.32 | +15.5% | 2.50B | +6.3% | 11 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 16, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Mar 4, 2025 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| Feb 12, 2025 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| Jul 31, 2024 | Deutsche Bank | Downgrade | Buy | Hold |
| Jul 25, 2024 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jul 1, 2024 | William Blair | Downgrade | Outperform | Market Perform |
| Apr 25, 2024 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Mar 26, 2024 | Raymond James | Maintained | Market Perform | Market Perform |
| Mar 25, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 14, 2023 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jul 31, 2023 | TD Cowen | Maintained | Market Perform | Market Perform |
| Jul 27, 2023 | Credit Suisse | Reiterated | Neutral | Neutral |
| Jul 6, 2023 | Jefferies | Downgrade | Buy | Hold |
| Jun 28, 2023 | Benchmark | Downgrade | Buy | Hold |
| Jun 27, 2023 | Benchmark | Downgrade | Buy | Hold |
| Jun 27, 2023 | Truist Securities | Maintained | Hold | Hold |
| Jun 7, 2023 | Truist Securities | Downgrade | Buy | Hold |
| Jun 6, 2023 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jun 6, 2023 | Benchmark | Reiterated | Buy | Buy |
| Jun 6, 2023 | Credit Suisse | Downgrade | Outperform | Neutral |
| May 8, 2023 | TD Cowen | Maintained | — | Market Perform |
| May 5, 2023 | Barclays | Maintained | — | Equal-Weight |
| May 4, 2023 | Truist Securities | Maintained | — | Buy |
| May 4, 2023 | Stephens & Co. | Reiterated | — | Equal-Weight |
| Apr 21, 2023 | Cantor Fitzgerald | Initiated | — | Neutral |
| Apr 13, 2023 | Truist Securities | Maintained | — | Buy |
| Mar 14, 2023 | Benchmark | Reiterated | — | Buy |
| Mar 14, 2023 | Stephens & Co. | Reiterated | — | Equal-Weight |
| Mar 13, 2023 | Barclays | Initiated | — | Equal-Weight |
| Feb 27, 2023 | Credit Suisse | Reiterated | — | Outperform |